Cerebrospinal fluid GABA levels in various neurological and psychiatric diseases.
Open Access
- 1 March 1982
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 45 (3) , 257-260
- https://doi.org/10.1136/jnnp.45.3.257
Abstract
Cerebrospinal fluid gamma-aminobutyric acid (CSF-GABA) was analysed by radioreceptor assay in 16 normal controls and 84 patients with various neurological and psychiatric diseases. In patients with spinocerebellar degeneration, neuro-Behçet's syndrome and Parkinson's disease, CSF-GABA levels were decreased. On the other hand, increased CSF-GABA levels were detected in patients with meningitis.This publication has 13 references indexed in Scilit:
- Cerebrospinal fluid GABA levels in involuntary movement disordersBrain Research Bulletin, 1980
- Levels of -Aminobutyric Acid in Cerebrospinal Fluid in Various Neurologic DisordersArchives of Neurology, 1980
- Huntington's DiseaseArchives of Neurology, 1978
- Neurobiology and pharmacology of Huntington's diseaseLife Sciences, 1977
- Epilepsy and γ-Aminobutyric Acid-Mediated InhibitionPublished by Elsevier ,1975
- Amino Acid Composition of Cerebrospinal Fluid in Acute Neuroinfections in ChildrenArchives of Neurology, 1975
- L-Glutamic Acid Decarboxylase in Parkinson's Disease: Effect of L-Dopa TherapyNature, 1973
- Biochemical-physiology correlations in studies of the γ-aminobutyric acid systemBrain Research, 1968
- REGIONAL DISTRIBUTION OF γ‐AMINOBUTYRIC ACID (GABA) IN BRAIN OF THE RHESUS MONKEY*Journal of Neurochemistry, 1968
- CHOLINERGIC AND NON‐CHOLINERGIC NERVE ENDINGS IN RAT BRAIN–IJournal of Neurochemistry, 1962